X3 Clean
- Manufacturer
- X3 Labs Inc.
- Effective date
- 2025-09-03
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 11
- Source
- full-release
- Hydrated at
- 2026-06-01 01:12:28
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Active Ingredient
Benzalkonium Chloride 0.13%
Purpose
Antimicrobial
Use
To decrease bacteria on the skin that could cause disease.
Warnings
For external use only. Do not use in or near eyes. In case of contact with eyes, flush thoroughly with water.
OTC - STOP USE SECTION
Stop use and ask doctor if skin irritation develops.
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions Apply a small amount to palms and rub hands thoroughly until completely dry.
WARNINGS AND PRECAUTIONS SECTION
Other Information Do not freeze.
INACTIVE INGREDIENT SECTION
Inactive Ingredients Purified Water, Glycerin, Cocamidopropyl Betaine.
OTC - QUESTIONS SECTION
Questions?
www.x3clean.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 26550-001-12 | X3 Clean | 75 mL in 1 BOTTLE | AEROSOL, FOAM | 75 | 11 | |
| 26550-001-14 | X3 Clean | 250 mL in 1 BOTTLE | AEROSOL, FOAM | 250 | 11 | |
| 26550-001-16 | X3 Clean | 1000 mL in 1 BOTTLE | AEROSOL, FOAM | 1000 | 11 | |
| 26550-001-18 | X3 Clean | 1000 mL in 1 CARTRIDGE | AEROSOL, FOAM | 1000 | 11 | |
| 26550-001-20 | X3 Clean | 4000 mL in 1 BOTTLE | AEROSOL, FOAM | 4000 | 11 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzalkonium Chloride | ACTIVE INGREDIENT | F5UM2KM3W7 | 1 | |
| Benzalkonium | ACTIVE MOIETY | 7N6JUD5X6Y | 1 | |
| Cocamidopropyl Betaine | INACTIVE INGREDIENT | 5OCF3O11KX | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- X3 Clean
- BENZALKONIUM CHLORIDE
- WATER
- GLYCERIN
- COCAMIDOPROPYL BETAINE
- BENZALKONIUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 26550-001 | 26550-001-12, 26550-001-14, 26550-001-16, 26550-001-18, 26550-001-20 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| COCAMIDOPROPYL BETAINE | 5OCF3O11KX | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| X3 Clean | BENZALKONIUM CHLORIDE | X3 Labs Inc. | a8eedcfd-3b97-497a-9a34-d59b0dd78439 | 2025-09-03 | Warnings | 26550-001-20 26550-001-12 26550-001-14 26550-001-18 26550-001-16 26550-001 26550000118 26550000114 26550000112 26550000116 26550000120 3de9253f-bb5c-71c1-e063-6294a90a71ca a8eedcfd-3b97-497a-9a34-d59b0dd78439 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




